About us   Contacts   Links   Information in Russian 
Research programms
Publications

The list of publications in 2021


  1. Novik A.A, Ionova T.I. Guidelines of Quality of Life Research in Medicine. Ed. by Academ. J.L. Shevchenko. Moscow, RAEN Publisher; 2021 616 P. (in Russ.).
  2. The quality of life of patients with myeloproliferative neoplasms and the attitude of patients and doctors to the problems of the disease and treatment: results of the national observational program MPN-QOL-2020. Ed. T.?I.?Ionova.? M.: Prakticheskaya medicina, 2021.?- 36 P.
  3. Ionova T.I., Andrievskikh M.I., Amdiev A.A., et al. Outcomes of brentuximab vedotin as >3 line treatment in patients with relapsed/refractory classical Hodgkin lymphoma: physicians and patients perspective. HemaSphere. 2021; 5, S2: 572.
  4. Ionova T.I., Andrievskikh M.I., Amdiev A.A., et al. Brentuximab vedotin for treatment in patients with relapsed/refractory classical Hodgkin lymphoma in a real world setting: clinical outcomes and impact on quality of life. Hematological Oncology. 2021; 39 (Issue S2): 442443.
  5. Ionova T., Vinogradova O., Kochkareva Y., et al. Ixazomib-lenalidomide-dexamethasone (IRd) treatment for patients with relapsed/refractory multiple myeloma (RRMM) in a real-world setting: physicians and patients perspective (COMy e-poster).
  6. Laane E., Ionova T., Oliva E.N., et al. Appraisal of the consistent use and reporting of patient-reported outcomes in multiple myeloma clinical trials: does it matter? HemaSphere. 2021; 5, S2: 570.
  7. Andreas M., Salek S., Oliva E.N., Ionova T., et al. Patient-reported outcomes in clinical trials for multiple myeloma: Where we are. Journal of Clinical Oncology, 2021; 39:15_suppl, e18615-e18615. https://doi.org/10.1200/jco.2021.39.15_suppl.e18615.
  8. Zherniakova .., Kostroma I.I., Bessmeltsev S.S., Ribakova L.P., Alexanjan L.R., Nikitina T.P., Porfireva N.M., Ionova T.I., Chechetlin A.V., Gritsaev S.V. Quality of life, symptom burden and serum malonic dialdehide concentration in multiple myeloma patients after autologous stem cell transplantation. Biomedical journal Medline.ru. 2021; 22: 4961.
  9. Shevchenko Yu.L., Ionova T.I., Melnichenko V.Ya., Nikitina T.P. Quality of life in the population of Russian Federation during pandemic of COVID-19. Bulletin of Pirogov National Medical & Surgical Center. 2021; 16 (1): 74-83. (In Russ.) https://doi.org/10.25881/BPNMSC.2021.97.90.013.
  10. Shevchenko Y.L., Ionova T.I., Melnichenko V.Ya., Nikitina T.P. Quality of Life and Mental Health in Russian General Population and Burnout among Physicians During Covid-19 Pandemic. Bulletin of Pirogov National Medical & Surgical Center. 2021; 16 (3); 4-11.
  11. Melnichenko V.Y., Fedorenko D.A., Nikitina T.P., Porfirieva N.M., Nikolaev I.S., Ionova T.I. Autologous haematopoietic stem cell transplantation with low-intensity conditioning regimens in relapsing remitting multiple sclerosis: clinical outcomes and quality of life. CT. 2021; 10 (2): 4553. doi2010.18620/ctt-1866-8836-2021-10-2-45-53.
  12. Melikyan A.L., Kovrigina A.M., Subortseva I.N., et al. National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020). Clinical oncohematology. 2021; 14 (2): 26298. (In Russ.). DOI: 10.21320/2500-2139-2021-14-2-262-298.
  13. Ionova T.I., Polishchuk L.O., Nikitina T.P., Vetshev F.P. Linguistic and cultural adaptation of the Russian version of symptom assessment questionnaire in patients with gastrointestinal cancer MDASI-GI. Bulletin of the Multinational Center for Quality of Life Research. 2021; 3738: 6268.
  14. Zhukovskaya E.V., Abrosimov A.B., Ionova T.I., et al. Comparative assessment of quality of life in children and adolescents with severe blood diseases during rehabilitation after the completion of antitumor therapy and hematopoietic stem cell transplantation. Bulletin of the Multinational Center for Quality of Life Research. 2021; 3738: 4253.
  15. Zherniakova A.A., Ionova T.I., Gritsaev S.V. Quality of life assessment in patients with multiple myeloma and its interpretation in clinical practice. Bulletin of the Multinational Center for Quality of Life Research. 2021; 3738: 6979.








©

(last update): 03-10-2023